Representation of bacterial biofilm as an impregnable castle in the prostate.
Schematic representation: bacterial biofilm as a protective barrier against immune defenses and antibiotic penetration.

Are you unable to get rid of prostatitis that keeps coming back despite multiple courses of antibiotic therapy? In recent years, some researchers have begun investigating a possible explanation: the presence of an intraprostatic bacterial biofilm, associated with prostatic calcifications, suggesting that in some patients these calcifications may contribute to the persistence of infection.

In this article, you will learn:

  • what a bacterial biofilm is;
  • why bacteria within biofilms are difficult to eradicate;
  • what prostatic calcifications are and how they form;
  • why some cases of prostatitis become chronic;
  • what current scientific research tells us;
  • what therapeutic strategies may be considered.

The aim is to help you understand a complex subject in simple language, without causing unnecessary alarm while, at the same time, not underestimating symptoms.

What Is a Bacterial Biofilm? Imagine a Fortified City

When we think about bacteria, we often imagine isolated cells floating freely in the fluids of our body. In reality, many bacteria prefer to live in organized communities as a means of protecting themselves.

To do this, they build a kind of protective shell, composed of sugars, proteins and other substances produced by the bacteria themselves. This structure is called a biofilm.

Once a biofilm has formed:

  • antibiotics have greater difficulty reaching the bacteria;
  • immune system cells have greater difficulty eliminating them;
  • some bacteria enter a “dormant” state, becoming less susceptible to drugs.

It is precisely this protective ability that makes biofilms an important factor in many chronic infections.

Why Are Bacteria Within a Biofilm Difficult to Eliminate?

Within a biofilm, many bacteria slow down their metabolism, making them less susceptible to drugs that act primarily on actively multiplying cells. Biofilms also create microenvironments that favor bacterial survival. In addition, some cells known as “persister cells” may survive treatment without necessarily being genetically resistant to antibiotics.

Clinical ParameterFree-Living Bacteria (Planktonic)Bacteria Within Biofilm
Drug AccessibilityEasily accessible for therapeutic agentsProtected by extracellular matrix (EPS)
Growth & ReplicationRapid growth and cell divisionSlow metabolism (dormant / persister state)
Antibiotic SusceptibilityHigh susceptibility to standard dosesMay require up to 1000-fold higher concentrations
Immune ResponseReadily cleared by phagocytes and antibodiesPhagocytosis impaired by matrix barrier
Infection CourseTypically acute and responsive to therapyPersistent, relapsing, or chronic course
Clinical comparison: susceptibility of free-living bacteria versus bacteria embedded in intraprostatic biofilm.

What Are Prostatic Calcifications and Why Do They Form?

Prostatic calcifications are small deposits of calcium salts that form within the prostate gland. During an ultrasound examination, they may appear as small, very bright white spots. They are extremely common, and many men discover them incidentally during an examination performed for other reasons.

In most cases, they have no pathological significance, cause no symptoms and require no treatment. Several mechanisms have been proposed to explain their formation, including chronic inflammation, stagnation of prostatic secretions, obstruction of small glandular ducts, aging of the prostate, and reflux of urine into the prostatic ducts.

In practical terms, when the normal drainage of prostatic secretions is impaired, cellular debris and mineral substances may accumulate and gradually undergo calcification.

Infographic showing the 6 stages of prostatic calcification formation.
The 6 stages of prostatic calcification from ductal obstruction to mineral aggregation.

How Do Bacteria Reach the Prostate?

There are three possible routes by which bacteria may reach the prostate:

  1. Ascending through the urethra: Bacteria may reach the prostate by ascending through the urethra, particularly in the presence of urinary tract infections.
  2. Reflux of infected urine: Reflux of infected urine into the prostatic ducts facilitates the entry of microorganisms into the gland.
  3. Rectal and lymphatic pathways: Spread from the rectal ampulla through shared lymphatic drainage between the rectal wall and the prostate, explaining prostatitis in patients with chronic constipation or altered bowel motility.

What Is an Intraprostatic Bacterial Biofilm?

The prostate is a gland crossed by dozens of small ducts that carry prostatic fluid, an important component of semen. If bacteria manage to reach these ducts, they may adhere to their walls and gradually begin to produce a biofilm.

At this stage, a man may experience no symptoms at all. Over time, however, the immune system recognizes the presence of the bacteria and attempts to eliminate them. Chronic inflammation may then develop and manifest with symptoms such as:

  • pelvic pain;
  • discomfort during urination;
  • urinary burning;
  • pain after ejaculation;
  • a sensation of heaviness in the perineal area.

Not all patients with these symptoms have a bacterial biofilm, but its presence is considered a plausible contributing factor in cases of recurrent chronic bacterial prostatitis.

Are All Prostatic Calcifications Dangerous?

Absolutely not. This is perhaps the most reassuring message: receiving an ultrasound report mentioning “prostatic calcifications” does not mean you have a severe disease. Many men live with these calcifications without experiencing any symptoms.

They become clinically significant when:

  • they are numerous;
  • they are located near the main prostatic ducts;
  • they are associated with recurrent prostatitis;
  • they coincide with persistent pain or urinary symptoms.

The Link Between Biofilms and Calcifications: What Does Research Show?

For many years, calcifications were considered mere physiological signs of prostatic aging. In recent years, however, microscopic analysis of calcifications removed during surgery revealed structures consistent with bacterial biofilms and isolated viable bacteria capable of biofilm formation. These findings support the concept that calcifications may serve as a protective surface on which bacteria adhere and establish reservoirs.

A Vicious Cycle That May Be Difficult to Break: How Intraprostatic Bacterial Biofilm Forms

A possible pathogenic sequence observed clinically is:

Bacteria enter the prostate → adhesion to prostatic ducts → biofilm formation → persistent inflammation → stagnation of secretions → formation or persistence of calcifications → potential bacterial persistence → recurrent inflammation.

This mechanism should not be interpreted as occurring in every patient with chronic prostatitis or prostatic calcifications. It represents one of the major mechanisms currently being investigated in recalcitrant cases.

Diagram of the 4 stages of biofilm formation in the prostate.
The 4 stages: reversible adhesion, irreversible attachment, matrix maturation, and periodic bacterial dispersion.

Why Do Antibiotics Sometimes Seem to Work… and Then Everything Starts Again?

Many patients describe a similar experience: “I take an antibiotic, I feel better for a month, and then the symptoms come back.”

Biofilm provides a clear explanation. An antibiotic may eliminate the bacteria that are more exposed, while microorganisms protected within the biofilm may survive. Once treatment has ended, these microorganisms may begin multiplying again and potentially reactivate inflammation.

However, biofilm is not the only possible explanation for recurrence. Other factors may also contribute, including functional abnormalities of the prostate, infections that have not been completely eradicated, or non-infectious causes of pelvic pain.

Which Symptoms May Suggest a Chronic Problem?

One of the most frustrating features of chronic prostatitis is that symptoms may come and go. There may be periods when symptoms almost disappear and others when they suddenly return, sometimes after weeks or months of feeling well. This pattern may lead patients to believe that an infection has been completely eliminated, when chronic inflammation may still persist or, in some cases, an infection may be difficult to eradicate.

The most common symptoms include:

  • pain or discomfort in the perineum, the area between the testicles and anus;
  • burning during urination;
  • burning or pain after ejaculation;
  • increased urinary frequency and urgency;
  • difficulty emptying the bladder completely;
  • discomfort in the testicles or suprapubic region;
  • pain that may radiate to the groin, back or inner thighs.

Not all these symptoms need to be present. Some men experience only mild discomfort, while others report persistent pain that affects work, sleep, physical activity and sexual life.

When Do Prostatic Calcifications Become Important?

Many men live with small prostatic calcifications without even knowing they have them. They may become clinically relevant when they are associated with:

  • recurrent prostatitis;
  • repeated urinary tract infections;
  • chronic pelvic pain;
  • persistent ultrasound abnormalities.

In these cases, the urologist may consider calcifications as one element of the overall clinical picture, but they are almost never the sole cause of symptoms. It is important to remember that two men with very similar prostatic calcifications may have completely different clinical situations: one may have no symptoms at all, while the other may experience chronic prostatitis with significant symptoms. For this reason, an ultrasound report should always be interpreted together with the patient’s medical history, specialist examination and, when indicated, microbiological investigations.

How Is the Diagnosis Made?

There is no single test capable of confirming the presence of a bacterial biofilm in routine clinical practice. Diagnosis is therefore based on a combination of clinical information and investigations.

1. Urological Examination
The first step is a careful assessment of the patient’s symptoms. The urologist may ask when the symptoms first appeared, how many recurrences have occurred, which antibiotics have already been taken, whether symptoms worsen after ejaculation, and whether urinary symptoms are present. Validated questionnaires such as the NIH-CPSI may also be used to assess pain severity, urinary symptoms and their impact on quality of life.

2. Digital Rectal Examination
Digital rectal examination can help differentiate prostatitis from pelvic floor pain syndromes. It allows the urologist to assess prostate size, consistency, tenderness, and particularly sensitive areas. By itself, it cannot diagnose a biofilm, but it can provide useful information about the condition of the gland.

3. Transrectal Prostate Ultrasound
Ultrasound is one of the key diagnostic tools. It may reveal calcifications, inflammatory changes, dilatation of the prostatic ducts, cysts, and enlargement of the prostate. It is important to remember that the biofilm itself cannot be seen on ultrasound. Ultrasound may show changes associated with inflammation, but it does not directly demonstrate the presence of bacteria.

4. Microbiological Tests
When bacterial prostatitis is suspected, the following tests may be considered: urine culture, semen culture, culture of expressed prostatic secretions, and Meares-Stamey test (in centers where it is performed). These tests may help identify the responsible microorganism and guide antibiotic selection. A negative culture does not automatically exclude chronic prostatitis, as bacteria embedded within biofilms may escape detection.

Is MRI Useful?
In recent years, multiparametric MRI of the prostate has become increasingly common. However, in the specific diagnostic assessment of prostatitis, it generally does not provide additional information compared with a well-performed transrectal ultrasound. MRI may be requested when the urologist considers it necessary to investigate the clinical picture further or to exclude other conditions.

Chart showing the success rate of antibiotic therapies and the cycle of chronic prostatitis recurrences.
The cycle of chronic recurrence: temporary bacterial reduction followed by regrowth and symptom relapse.
Clinical Insight: Did You Know?

Biofilms are not unique to the prostate gland. They play a decisive role in dental plaque, chronic wound infections, prosthetic joint colonization, urinary catheters, and chronic respiratory diseases.

Chronic prostatitis is one of the urological conditions that most severely impairs quality of life, with patient-reported scores comparable to Crohn’s disease or chronic myocardial infarction.

False Myths to Dispel

False Myth: “Prostate calcifications represent a tumor.”

False. Calcifications are benign calcium deposits. They are not cancerous and do not transform into malignancy.

False Myth: “Taking stronger systemic antibiotics will definitely eradicate the biofilm.”

Not necessarily. Biofilm barriers require specialized protocols, localized treatments, or multimodal regimens tailored to individual susceptibility.

False Myth: “Having prostatic calcifications always requires surgical removal.”

In the vast majority of cases, no. Most calcifications are asymptomatic and do not necessitate surgical intervention.

When Is It Advisable to Consult a Urologist?

Schedule a specialist urological evaluation if:

  • You experience recurrent episodes of prostatitis or urinary tract infections;
  • Pelvic, perineal, or testicular pain has persisted for more than three months;
  • You notice blood in your semen (hematospermia) or urine;
  • Urinary burning or frequency fails to respond to empirical medical therapies;
  • Elevated PSA levels require detailed differential diagnosis;
  • Ultrasound examinations indicate calcifications associated with active symptoms.

In Conclusion

Prostatic calcifications are a common finding, particularly in adult and older men, and in most cases are incidental, asymptomatic, and do not require specific treatment. Their presence alone should therefore not be considered evidence of chronic prostatitis or persistent bacterial infection.

However, in patients with recurrent bacterial prostatitis, persistent urinary or pelvic symptoms, or repeated microbiologically documented infections, prostatic calcifications may be clinically relevant and should be interpreted in the context of the patient’s symptoms, microbiological findings, and imaging features.

Bacterial biofilm represents one possible mechanism that may contribute to bacterial persistence and recurrent infection. Bacteria embedded within a biofilm may be more difficult to eradicate because of reduced antimicrobial penetration, altered bacterial metabolic activity, and the presence of persister cells. Nevertheless, the presence of a biofilm cannot currently be demonstrated by routine prostate ultrasound, and its role should not be assumed in every patient with chronic prostatitis or prostatic calcifications.

For this reason, recurrent or persistent symptoms require an individualized urological assessment aimed at distinguishing chronic bacterial prostatitis from chronic pelvic pain syndrome and other possible causes of urinary or pelvic symptoms. Microbiological investigations and imaging should be selected according to the clinical context, allowing treatment to be directed at the most likely underlying mechanism rather than at the presence of calcifications alone.

Scientific Bibliography

Clinical Guidelines

  • European Association of Urology (EAU). Guidelines on Urological Infections.
  • European Association of Urology (EAU). Guidelines on Chronic Pelvic Pain.
  • American Urological Association (AUA). Male Chronic Pelvic Pain Guideline.

Biofilm Research

  • Costerton JW, Stewart PS, Greenberg EP. Bacterial Biofilms: A Common Cause of Persistent Infections. Science. 1999.
  • Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial Biofilms: From the Natural Environment to Infectious Diseases. Nature Reviews Microbiology. 2004.
  • Donlan RM, Costerton JW. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clinical Microbiology Reviews. 2002.

Prostatitis and Prostatic Calcifications

  • Nickel JC. Prostatitis. Canadian Urological Association Journal.
  • Krieger JN et al. NIH Consensus Classification of Prostatitis.
  • Geramoutsos I et al. Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. European Urology.
  • Dessombz A et al. Prostatic calcifications: a role for bacteria? PLOS ONE.
This entry was posted in Uncategorized. Bookmark the permalink.
[iub-pp-button]